Improving alcohol use disorder treatment by targeting sleep
Targeting sleep homeostasis to improve alcohol use disorder treatment outcomes
This study is looking at how improving sleep can help adults with alcohol use problems feel better and drink less, using online therapy for insomnia to see if it makes a difference for those who have trouble sleeping.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10687864 on NIH RePORTER |
What this research studies
This research investigates how addressing sleep issues can enhance treatment outcomes for adults with alcohol use disorder (AUD). It focuses on the use of cognitive behavioral therapy for insomnia (CBTi) delivered via telemedicine to help patients improve their sleep quality. The study will recruit 150 adults entering treatment for AUD who also experience insomnia, assessing the impact of CBTi on their drinking behavior and overall well-being. By understanding the relationship between sleep and relapse, the research aims to provide a more effective treatment approach for those struggling with AUD.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are undergoing treatment for alcohol use disorder and also suffer from insomnia.
Not a fit: Patients who do not have alcohol use disorder or those without insomnia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment outcomes and reduced relapse rates for individuals with alcohol use disorder.
How similar studies have performed: Previous pilot studies have shown promising results for cognitive behavioral therapy for insomnia in improving sleep and daytime symptoms among patients with alcohol use disorder, indicating potential for success in this approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Arnedt, J. Todd — University of Michigan at Ann Arbor
- Study coordinator: Arnedt, J. Todd
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.